News
1d
TipRanks on MSNGSK’s New Study on GSK5764227: A Potential Game-Changer in Gastrointestinal Cancer Treatment
GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
2d
TipRanks on MSNGSK’s Promising Study on Belimumab for Systemic Sclerosis Lung Disease
GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...
GlaxoSmithKline Pharmaceuticals reports a 12% increase in net profit to Rs 279 crore for the June quarter despite a slight ...
The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.
Delhi Police have busted a medicine racket making counterfeit life-saving drugs using the names of big pharma companies such ...
GlaxoSmithKline said it would buy cancer-focused drug company Tesaro for about $4.16 billion, positioning the health-care giant in a promising, but fiercely competitive, area of medicine.
The Drug Regulatory Authority of Pakistan (DRAP) has issued a voluntary recall alert for two widely used antibiotic suspensions manufactured by ...
Less than two months after GlaxoSmithKline pledged to cap out-of-pocket costs for its inhalers at $35 a month, Sen. Maggie Hassan (D-N.H.) is accusing the company of circumventing that vow through ...
GlaxoSmithKline Pharmaceuticals' shares fell by 2% in Thursday's morning trade, reflecting a bearish market sentiment. The company is currently trading at Rs 2,680.10 per share.
GlaxoSmithKline LLC will pay $3 billion and plead guilty to promoting two popular drugs for unapproved uses and to failing to disclose important safety information on a third in the largest heal ...
GlaxoSmithKline PLC GSK 0.79% has reported positive results from a study of a cancer drug in a clinical trial that a senior figure in the company said justified the decision to acquire cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results